Tag: biopharma

The recognition marks a significant milestone in 22 year old entrepreneur's journey to revolutionize the pharmaceutical industry and ensure that quality healthcare reaches every Indian at significantly reduced costs

Significant advancements in treatments for gastrointestinal (GI) disorders are anticipated, driven by innovations from both large and small pharma companies, says GlobalData

GlobalData’s Bio/Pharmaceutical Outsourcing report sheds light on the reliance of smaller pharma companies on contract development and manufacturing organizations (CDMOs) for production

The new site will increase Syngene's total single-use bioreactor capacity to 50,000L for large molecule discovery, development, and manufacturing services

The 50,000-square-foot dedicated state-of-the-art CGT facility represents the next milestone in BBIL’s long-standing mission to deliver targeted, life-saving treatments

The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation, Merger & Acquisition (M&A) among others

Biologics drug substance facility in Baltimore expected to enhance global innovator flexibility

The Cover Story tracks the surge in the big-ticket investments by MNCs to spearhead the next wave of innovation. Read interview of Shailendra Vyas CEO and Director, Bioheaven360 Genotec. Expert Insights by Shereef Rehuman, MD, ICEXPO Consults and Daara Patel, Secretary General, IDMA; and Ninad Karandikar, Co-founder, Stance Health

The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations

Quadrivalent Inactivated Influenza vaccine - VaxiFlu - 4 to offer seasonal protection against 4 new virus strains